* Cross Country Healthcare Inc CCRN.OQ CCRN.O is expected
to show a rise in quarterly revenue when it reports results on
November 3.
* The Boca Raton, Florida-based company is expected to report a
65.2% increase in revenue to $320.474 million from $193.97
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Cross Country
Healthcare Inc is for earnings of 34 cents per share. For the
same quarter last year, the company reported earnings of 12
cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Cross Country
Healthcare Inc is $22, about 2.9% above its last closing price
of $21.37.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 302021 0.40 0.40 0.47 Beat 18.7
Mar. 312021 0.34 0.34 0.58 Beat 69.9
Dec. 312020 0.09 0.09 0.19 Beat 121.6
Sep. 302020 -0.03 -0.03 0.12 Beat 508.4
Jun. -0.03 -0.03 0.16 Beat 591.3
302020
Mar. 312020 -0.02 -0.02 -0.01 Beat 39.7
Dec. 312019 0.06 0.06 0.07 Beat 21
Sep. 302019 0.01 0.01 0.05 Beat 297.8
This summary was machine generated November 2 at 02:06 GMT. All
figures in US dollars unless otherwise stated